Program & CMC strategy
End-to-end review of your program, identification of technical and CMC risks, and development roadmaps aligned to your funding, resources, and partnering plans.
ArtProtein provides two complementary sets of services for antibody and recombinant protein programs in CHO and HEK:
All services are delivered by professionals with more than 20 years of experience in biologics development, CMC, and regulatory work, including USDA 9CFR–related studies.
End-to-end review of your program, identification of technical and CMC risks, and development roadmaps aligned to your funding, resources, and partnering plans.
CHO vs HEK platform recommendations, with stable and transient expression strategies tailored to speed, risk, and long-term supply needs for mAbs and recombinant proteins.
Fed-batch, media/feed, and purification concepts that anticipate later scale-up, critical process parameters, and manufacturability requirements.
Study designs for transient and stable expression, upstream optimization in scale-down models and process-controlled bioreactors, and purification screening and robustness work.
Technical content for CMC sections, development summaries, and USDA 9CFR proposals, study plans, and final reports that clearly explain what was done and why.
Non-GMP laboratory services designed to generate practical data and material that can be carried into GMP manufacturing and regulatory submissions.
Transient expression in CHO and HEK for fast-turnaround material to support feasibility, assay setup, and early screening, and stable cell line development for longer-term supply and tech transfer.
Process development in scale-down models (deep-well plates, shake flasks, small bioreactors) with translation into process-controlled bioreactors at bench and larger scales, using DoE-driven optimization.
Lab-scale purification schemes and basic analytical panels (titer, purity, aggregation and key attributes) structured so results can be reused in CMC and tech-transfer documentation.
Process descriptions, control strategies, and development reports prepared for GMP partners, plus structured handover packages and support during engineering runs as needed.